Evidence map›Paper›PMID 31284444›Full record

ArticleMolecules (Basel, Switzerland)2019

Treatment with, Resveratrol, a SIRT1 Activator, Prevents Zearalenone-Induced Lactic Acid Metabolism Disorder in Rat Sertoli Cells.

Peirong Cai, Nannan Feng, Wanglong Zheng, Hao Zheng, Hui Zou, Yan Yuan, Xuezhong Liu, Zongping Liu, Jianhong Gu, Jianchun Bian

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fine Particulate Matter (Environmental health perspectives · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Peirong CaiCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China.
Nannan FengCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China.
Wanglong ZhengCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China.
Hao ZhengCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China.
Hui ZouCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China.
Yan YuanCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China.
Xuezhong LiuCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China.
Zongping LiuCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China.
Jianhong GuCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China. jhgu@yzu.edu.cn.
Jianchun BianCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, Jiangsu, China. jcbian@yzu.edu.cn.ORCID 0000-0001-8023-0751
Yangzhou University · CN

Funding

National Key Research and Development Program of China No. 2016YFD0501208Priority Academic Program Development of Jiangsu Higher Education Institutions PAPD
6 · The paper itself

Abstract

Zearalenone (ZEA) interferes with the function of the male reproductive system, but its molecular mechanism has yet to be completely elucidated. Sertoli cells (SCs) are important in the male reproductive system. Silencing information regulator 1 (SIRT1) is a cell metabolism sensor and resveratrol (RSV) is an activator of SIRT1. In this study we investigated whether SIRT1 is involved in the regulation of ZEA-induced lactate metabolism disorder in SCs. The results showed that the cytotoxicity of ZEA toward SCs increased with increasing ZEA concentration. Moreover, ZEA induced a decrease in the production of lactic acid and pyruvate of SCs and inhibited the expression of glycolytic genes and lactic acid production-related proteins. ZEA also led to a decreased expression of SIRT1 in energy receptors and decreased ATP levels in SCs. However, the ZEA-induced cytotoxicity and decline in lactic acid production in SCs were alleviated by the use of RSV, which is an activator of SIRT1. In summary, ZEA decreased lactic acid production in SCs, while the treatment with an SIRT1 activator, RSV, restored the inhibition of lactic acid production in SCs and reduced cytotoxicity of ZEA toward SCs.

Indexed as

Adenosine TriphosphateAnimalsCell DeathCell ProliferationCell SurvivalLactic AcidMaleRats, WistarResveratrolSertoli CellsSirtuin 1ZearalenoneAdenosine TriphosphateLactic AcidResveratrolSirtuin 1Zearalenonelactic acidresveratrolSertoli cellsSIRT1zearalenone

Identifiers

PMID31284444
PMCPMC6651738
OpenAlexW2954932280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.